We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Software Tool Improves Analysis of Complex Spatial Data from Tissues

By LabMedica International staff writers
Posted on 09 Oct 2025

Advances in spatial omics have enabled scientists to map the distribution of RNA and proteins within intact tissues, offering powerful insights into how cells behave and interact in both health and disease. More...

However, as these datasets grow in complexity and scale, the main challenge has shifted from data generation to data interpretation. Researchers now require tools that can simplify and standardize analysis while accommodating the diverse types of spatial data produced by emerging technologies. To address this, a new software platform has been developed to help streamline the study of tissue structure and molecular organization.

Researchers from the Icahn School of Medicine at Mount Sinai (New York, NY, USA), Boston Medical Center (Boston, MA, USA), and collaborators have created Giotto Suite, a modular software ecosystem designed to analyze and integrate spatial omics data. Built using the R programming language, Giotto Suite allows scientists to work with datasets from multiple spatial platforms, resolutions, and modalities. Its flexible framework enables users to begin analysis from various points depending on research needs, bringing together different analytical steps into one unified environment.

Unlike previous tools that required combining multiple software packages, Giotto Suite consolidates the entire analytical pipeline—from data integration to visualization—into a single, scalable framework. It supports the study of molecular patterns within tissues, allowing researchers to explore cell interactions and spatial organization in both healthy and diseased states. The tool was introduced in Nature Methods, where it was described as a major step forward in computational spatial biology.

While the current version includes only a subset of analytical methods, the platform was designed for continuous evolution. Future updates will expand the available tools, enhance interoperability with external software, and provide more comprehensive training resources for scientists. The team plans to apply the system in their own investigations of cancer and neurodegenerative diseases while refining its features based on community feedback. The software is freely available at giottosuite.com to encourage widespread adoption.

The researchers envision the platform helping scientists uncover how molecular organization within tissues influences disease mechanisms and therapeutic responses. By simplifying data analysis and integration, Giotto Suite may accelerate discoveries in spatial biology and foster collaboration between computational and experimental researchers. Its adaptability also makes it suitable for future spatial technologies as the field continues to evolve.

“Many existing tools require users to combine multiple packages to complete a full analysis,” said co-senior corresponding author Ruben Dries, PhD. “This tool brings those steps into a single framework, aiming to streamline the process. We also developed it with scalability in mind to accommodate the growing size and complexity of spatial datasets. Our goal was to develop a platform that helps other researchers uncover new insights from their spatial data.”

Related Links:
Icahn School of Medicine at Mount Sinai
Boston Medical Center


New
Gold Member
Hybrid Pipette
SWITCH
Portable Electronic Pipette
Mini 96
Blood Glucose Test Strip
AutoSense Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Impaired vascular function in patients with chronic kidney disease (A K Grotle et al., Am J Physiol Renal Physiol (2025). DOI: 10.1152/ajprenal.00158.2025)

Kidney Disease Blood Marker Could Also Identify Cardiovascular Problems

Chronic kidney disease (CKD) affects millions worldwide and is strongly linked to cardiovascular complications rather than kidney failure itself. Patients with CKD often experience vascular dysfunction... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The tool enables scientists to track real-time fluctuations in T cell function with unprecedented speed and precision (Photo courtesy of Shutterstock)

Luminescent Probe Measures Immune Cell Activity in Real Time

The human immune system plays a vital role in defending against disease, but its activity must be precisely monitored to ensure effective treatment in cancer therapy, autoimmune disorders, and organ transplants.... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.